# A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)

> **NCT01918033** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 608 (actual)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Desloratadine 5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01918033
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-20
- **Primary completion:** 2014-01-26
- **Final completion:** 2014-01-26
- **Target enrollment:** 608 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01918033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01918033, "A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01918033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*